Editorial board

Anti-infectives

Prof. Arturo Casadevall, Albert Einstein College of Medicine, Bronx, NY, USA

Prof. Erik De Clercq, Rega Institute for Medical Research, Leuven, Belgium

Prof. Jack Sobel, Wayne State University School of Medicine, Detroit, MI, USA

Anti-inflammatory

Prof. Cezmi A Akdis, Swiss Institute of Allergy and Asthma Research, Davos, Switzerland

Prof. Paul Emery, University of Leeds, Leeds, UK

Dr. Daniel E Levy, DEL BioPharma, San Mateo, CA, USA

Prof. Fred Poordad, Texas Liver Institute and University of Texas Health San Antonio, San Antonio, TX, USA

Prof. Yoshiya Tanaka: University of Occupational and Environmental Health, Fukuoka, Japan

Cardiovascular & Renal

Prof. Gregory Y. H. Lip, Chair of Cardiovascular Medicine, University of Liverpool, Liverpool, UK

Dr. Daniel E Levy, DEL BioPharma, San Mateo, CA, USA

Prof. Giuseppe Mancia, University of Milano-Bicocca, Milan, Italy

Prof. Ron Waksman, Washington Hospital Center, Washington, DC, USA

Prof. Alberico L Catapano, University of Milan, Milan, Italy

Central & Peripheral Nervous Systems

Prof. Philip N Patsalos, The National Hospital for Neurology & Neurosurgery, London, UK

Prof. Michael Berk, IMPACT Institute, Deakin University, Burwood,Australia

Oncologic, Endocrine & Metabolic

Prof. Farhad Ravandi-Kashani, MD Anderson Cancer Center, Houston, TX, USA

Prof. Frank J Giles, Northwestern Medicine Developmental Therapeutics Institute, Chicago, IL, USA

Prof. Cesare Gridelli, Moscati Hospital, Avellino, Italy

Prof. Gordon Lynch University of Melbourne, Melbourne, Australia

Prof. Daniele Santini, University Campus Biomedico, Rome, Italy

Prof. Bruno Vincenzi: Campus Bio-Medico University, Rome, Italy

Pulmonary-Allergy, Dermatology, Gastrointestinal & Arthritis

Prof. Sir Peter J Barnes, National Heart and Lung Institute, London, UK

Prof. Paul Emery, University of Leeds, Leeds, UK

Prof. Paul Martin, University of Miami, Coral Gables, FL, USA